Early effects of a hypocaloric, mediterranean diet on laboratory parameters in obese individuals

Mediators of Inflammation

Volumn 2014, Issue , 2014, Pages

  Greco, Marta ^a   Chiefari, Eusebio ^a   Montalcini, Tiziana ^a   Accattato, Francesca ^a   Costanzo, Francesco S ^a   Pujia, Arturo ^a   Foti, Daniela ^a   Brunetti, Antonio ^a   Gulletta, Elio ^a  

^a UNIVERSITY MAGNA GRAECIA OF CATANZARO   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ADIPOCYTOKINE; ADIPONECTIN; ALANINE AMINOTRANSFERASE; ASPARTATE AMINOTRANSFERASE; C REACTIVE PROTEIN; CYSTATIN C; EPIDERMAL GROWTH FACTOR; FIBRINOGEN; GAMMA INTERFERON; GLUCOSE; HIGH DENSITY LIPOPROTEIN; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; INSULIN; INTERLEUKIN 10; INTERLEUKIN 1ALPHA; INTERLEUKIN 1BETA; INTERLEUKIN 2; INTERLEUKIN 4; INTERLEUKIN 6; INTERLEUKIN 8; LACTATE DEHYDROGENASE; LEPTIN; LOW DENSITY LIPOPROTEIN; MONOCYTE CHEMOTACTIC PROTEIN 1; NICOTINAMIDE PHOSPHORIBOSYLTRANSFERASE; PLASMINOGEN ACTIVATOR INHIBITOR 1; RESISTIN; TRIACYLGLYCEROL; TUMOR NECROSIS FACTOR ALPHA; VASCULOTROPIN; BIOLOGICAL MARKER;

ADULT; ALANINE AMINOTRANSFERASE BLOOD LEVEL; ANALYTICAL PARAMETERS; ANTHROPOMETRY; ARTICLE; ASPARTATE AMINOTRANSFERASE BLOOD LEVEL; BLOOD SAMPLING; BODY MASS; BODY WEIGHT; CALORIC RESTRICTION; FEMALE; FOLLOW UP; GLUCOSE BLOOD LEVEL; HOMEOSTASIS; HUMAN; INSULIN BLOOD LEVEL; INSULIN RESISTANCE; LACTATE DEHYDROGENASE BLOOD LEVEL; LIPOPROTEIN BLOOD LEVEL; LOW CALORY DIET; MAJOR CLINICAL STUDY; MALE; MEDITERRANEAN DIET; MIDDLE AGED; OBESITY; PARTIAL THROMBOPLASTIN TIME; PRIORITY JOURNAL; PROTHROMBIN TIME; TRIACYLGLYCEROL BLOOD LEVEL; WEIGHT REDUCTION; BLOOD; DIET; DIET THERAPY; PROSPECTIVE STUDY;

ADIPOKINES; ANTHROPOMETRY; BIOLOGICAL MARKERS; BODY MASS INDEX; CALORIC RESTRICTION; DIET; DIET, MEDITERRANEAN; EPIDERMAL GROWTH FACTOR; FEMALE; HUMANS; INSULIN; INSULIN RESISTANCE; L-LACTATE DEHYDROGENASE; LEPTIN; MALE; MIDDLE AGED; OBESITY; PROSPECTIVE STUDIES; WEIGHT LOSS;

EID: 84897009580     PISSN: 09629351     EISSN: 14661861     Source Type: Journal    
DOI: 10.1155/2014/750860     Document Type: Article

References (64)

1. World Health Organization, Obesity: preventing and managing the global epidemic. WHO Technical Report 2000 894 Geneva. Switzerland World Health Organization
2. Ogden C. L., Lamb M. M., Carroll M. D., Flegal K. M., Prevalence of Obesity in the United States, 2009-2010. NCHS Data Brief 2012 82 1 8
3. Ogden C. L., Carroll M. D., Curtin L. R., Lamb M. M., Flegal K. M., Prevalence of high body mass index in US children and adolescents, 2007-2008. Journal of the American Medical Association 2010 303 3 242 249 2-s2.0-74549159752 10.1001/jama.2009.2012
4. Vasan R. S., Pencina M. J., Cobain M., Freiberg M. S., D'Agostino R. B., Estimated risks for developing obesity in the Framingham Heart Study. Annals of Internal Medicine 2005 143 7 473 I12 2-s2.0-25444476701
5. Klein S., Burke L. E., Bray G. A., Blair S., Allison D. B., Pi-Sunyer X., Hong Y., Eckel R. H., Clinical implications of obesity with specific focus on cardiovascular disease: a statement for professionals from the American Heart Association Council on Nutrition, Physical Activity, and Metabolism. Circulation 2004 110 18 2952 2967 2-s2.0-8144231115 10.1161/01.CIR.0000145546.97738.1E (Pubitemid 39473623)
6. Poirier P., Eckel R. H., Obesity and cardiovascular disease. Current Atherosclerosis Reports 2002 4 6 448 453 2-s2.0-0036833669
7. Zimmet P., Alberti K. G. M. M., Global and societal implications of the diabetes epidemic. Nature 2001 414 6865 782 787 2-s2.0-0035856920 10.1038/414782a (Pubitemid 34000780)
8. Hossain P., Kawar B., El Nahas M., Obesity and diabetes in the developing world-a growing challenge. The New England Journal of Medicine 2007 356 3 213 215 2-s2.0-33846422032 10.1056/NEJMp068177 (Pubitemid 46143224)
9. Bray G. A., A Guide to Obesity and the Metabolic Syndrome 2011 CRC Press
10. Masouka H. C., Chalasani N., Nonalcoholic fatty liver disease: an emerging threat to obese and diabetic individuals. Annals of the New York Academy of Sciences 2013 1281 106 122 10.1111/nyas.12016
11. Hursting S. D., Dunlap S. M., Obesity, metabolic dysregulation, and cancer: a growing concern ad an inflammatory (and microenvironmental) issue. Annals of the New York Academy of Sciences 2012 1271 82 87 10.1111/j.1749-6632. 2012.06737.x
12. Vucenik I., Stains J. P., Obesity and cancer risk: evidence, mechanisms, and recommendations. Annals of the New York Academy of Sciences 2012 1271 37 43
13. Gharibeh T., Mehra R., Obstructive sleep apnea syndrome: natural history, diagnosis, and emerging treatment options. Nature and Science of Sleep 2010 2 233 255 2-s2.0-80054741795 10.2147/NSS.S6844
14. Berenbaum F., Eymard F., Houard X., Osteoarthritis, inflammation an obesity. Current Opinion in Rheumatology 2013 25 114 118 10.1097/BOR. 0b013e32835a9414
15. Farah C. S., Salome C. M., Asthma and obesity: a known association but unknown mechanism. Respirology 2012 17 3 412 421 2-s2.0-84858136834 10.1111/j.1440-1843.2011.02080.x
16. Haslam D. W., James W. P. T., Obesity. The Lancet 2005 366 9492 1197 1209 2-s2.0-25844457693 10.1016/S0140-6736(05)67483-1 (Pubitemid 41393598)
17. Withrow D., Alter D. A., The economic burden of obesity worldwide: a systematic review of the direct costs of obesity. Obesity Reviews 2011 12 2 131 141 2-s2.0-78851468865 10.1111/j.1467-789X.2009.00712.x
18. McCarthy M. I., Genomics, type 2 diabetes, and obesity. The New England Journal of Medicine 2010 363 24 2339 2350 2-s2.0-78649842241 10.1056/NEJMra0906948
19. Després J.-P., Lemieux I., Abdominal obesity and metabolic syndrome. Nature 2006 444 7121 881 887 2-s2.0-33845886915 10.1038/nature05488 (Pubitemid 46024995)
20. Tchernof A., Després J. P., Pathophysiology of human visceral obesity: an update. Physiological Reviews 2013 93 359 404 10.1152/physrev.00033. 2011
21. Rosito G. A., D'Agostino R. B., Massaro J., Association between obesity and a prothrombotic state: The Framingham Offspring Study. Journal of Thrombosis and Haemostasis 2004 91 638 639
22. Bachmayer C., Lammert A., Hasenberg T., Hammes H. P., Healthy obese and post-bariatric patients-metabolic and vascular patterns. Experimental and Clinical Endocrinology & Diabetes 2013 121 8 483 487
23. Bray G. A., Ryan D. H., Medical therapy for the patient with obesity. Circulation 2012 125 13 1695 1703 2-s2.0-84859294995 10.1161/CIRCULATIONAHA.111. 026567
24. Eckel R. H., Nonsurgical management of obesity in adults. The New England Journal of Medicine 2008 358 18 1941 1950 2-s2.0-42949153474 10.1056/NEJMcp0801652 (Pubitemid 351620114)
25. Blackburn G., Effect of degreee of weight loss on health benefits. Obesity Research 1995 3, supplement 2 211 216
26. Goldstein D. J., Beneficial health effects of modest weight loss. International Journal of Obesity 1992 16 6 397 415 2-s2.0-0026753155
27. Shai I., Schwarzfuchs D., Henkin Y., Shahar D. R., Witkow S., Greenberg I., Golan R., Fraser D., Bolotin A., Vardi H., Tangi-Rozental O., Zuk-Ramot R., Sarusi B., Brickner D., Schwartz Z., Sheiner E., Marko R., Katorza E., Thiery J., Fiedler G. M., Blüher M., Stumvoll M., Stampfer M. J., Weight loss with a low-carbohydrate, Mediterranean, or low-fat diet. The New England Journal of Medicine 2008 359 3 229 241 2-s2.0-47549110641 10.1056/NEJMoa0708681 (Pubitemid 352008438)
28. Wallace T. M., Levy J. C., Matthews D. R., Use and abuse of HOMA modeling. Diabetes Care 2004 27 6 1487 1495 2-s2.0-2542469144 10.2337/diacare.27.6.1487 (Pubitemid 38680001)
29. Hainer V., Toplak H., Mitrakou A., Treatment modalities of obesity: what fits whom? Diabetes Care 2008 31 2 S269 S277 2-s2.0-41149127672
30. Heggen E., Klemsdal T. O., Haugen F., Holme I., Tonstad S., Effect of a low-fat versus a low-gycemic-load diet on inflammatory biomarker and adipokine concentrations. Metabolic Syndrome and Related Disorders 2012 10 6 437 442 10.1089/met.2012.0012
31. Hotamisligil G. S., Inflammation and metabolic disorders. Nature 2006 444 7121 860 867 2-s2.0-33845866857 10.1038/nature05485 (Pubitemid 46024993)
32. Ouchi N., Parker J. L., Lugus J. J., Walsh K., Adipokines in inflammation and metabolic disease. Nature Reviews Immunology 2011 11 2 85 97 2-s2.0-79151484704 10.1038/nri2921
33. Shoelson S. E., Lee J., Goldfine A. B., Inflammation and insulin resistance. Journal of Clinical Investigation 2006 116 7 1793 1801 2-s2.0-33745861300 10.1172/JCI29069
34. Fernandez A. C., Casariego A. V., Rodreguez I. C., Pomar M. D. B., One-year effectiveness of two hypocaloric diets with different protein/carbohydrate ratios in weight loss and insulin resistance. Nutricion Hospitalaria 2012 27 6 2093 2101
35. Stern L., Iqbal N., Seshadri P., Chicano K. L., Daily D. A., McGrory J., Williams M., Gracely E. J., Samaha F. F., The effects of low-carbohydrate versus conventional weight loss diets in severely obese adults: one-year follow-up of a randomized trial. Annals of Internal Medicine 2004 140 10 778 785 2-s2.0-2442502479
36. Esposito K., Marfella R., Ciotola M., Di Palo C., Giugliano F., Giugliano G., D'Armiento M., D'Andrea F., Giugliano D., Effect of a Mediterranean-style diet on endothelial dysfunction and markers of vascular inflammation in the metabolic syndrome: a randomized trial. Journal of the American Medical Association 2004 292 12 1440 1446 2-s2.0-4544288392 10.1001/jama.292.12.1440 (Pubitemid 39258336)
37. Varady K. A., Tussing L., Bhutani S., Braunschweig C. L., Degree of weight loss required to improve adipokine concentrations and decrease fat cell size in severely obese women. Metabolism: Clinical and Experimental 2009 58 8 1096 1101 2-s2.0-67651092387 10.1016/j.metabol.2009.04.010
38. Deng Y., Scherer P. E., Adipokines as novel biomarkers and regulators of the metabolic syndrome. Annals of the New York Academy of Sciences 2010 1212 E1 E19 2-s2.0-79952259618
39. Kershaw E. E., Flier J. S., Adipose tissue as an endocrine organ. Journal of Clinical Endocrinology and Metabolism 2004 89 6 2548 2556 2-s2.0-2942650969 10.1210/jc.2004-0395 (Pubitemid 38766330)
40. Galic S., Oakhill J. S., Steinberg G. R., Adipose tissue as an endocrine organ. Molecular and Cellular Endocrinology 2010 316 2 129 139 2-s2.0-72449191699 10.1016/j.mce.2009.08.018
41. Rea R., Donnelly R., Resistin: an adipocyte-derived hormone. Has it a role in diabetes and obesity. Diabetes, Obesity and Metabolism 2004 6 3 163 170 2-s2.0-2342445056 10.1111/j.1462-8902.2004.00334.x (Pubitemid 38559695)
42. Arita Y., Kihara S., Ouchi N., Takahashi M., Maeda K., Miyagawa J.-I., Hotta K., Shimomura I., Nakamura T., Miyaoka K., Kuriyama H., Nishida M., Yamashita S., Okubo K., Matsubara K., Muraguchi M., Ohmoto Y., Funahashi T., Matsuzawa Y., Paradoxical decrease of an adipose-specific protein, adiponectin, in obesity. Biochemical and Biophysical Research Communications 1999 257 1 79 83 2-s2.0-0033515761 10.1006/bbrc.1999.0255 (Pubitemid 29299050)
43. Wauman J., Tavernier J., Leptin receptor signaling: pathways to leptin resistance. Frontiers in Bioscience 2011 16 7 2771 2793 2-s2.0-79959565386 10.2741/3885
44. Villanueva E. C., Myers M. G. Jr., Leptin receptor signaling and the regulation of mammalian physiology. International Journal of Obesity 2008 32 7 S8 S12 2-s2.0-58149499180 10.1038/ijo.2008.232
45. Jéquier E., Leptin signaling, adiposity, and energy balance. Annals of the New York Academy of Sciences 2002 967 379 388 2-s2.0-0036293591 (Pubitemid 34721923)
46. Vasselli J. R., Scarpace P. J., Harris R. B., Banks W. A., Dietary components in the development of leptin resistance. Advances in Nutrition 2013 4 2 164 175 10.3945/an.112.003152
47. Dagogo-Jack S., Fanelli C., Paramore D., Brothers J., Landt M., Plasma leptin and insulin relationships in obese and nonobese humans. Diabetes 1996 45 5 695 698 2-s2.0-0030012248 (Pubitemid 26142811)
48. Schwartz M. W., Prigeon R. L., Kahn S. E., Nicolson M., Moore J., Morawiecki A., Boyko E. J., Porte D. Jr., Evidence that plasma leptin and insulin levels are associated with body adiposity via different mechanisms. Diabetes Care 1997 20 9 1476 1481 2-s2.0-0030764045 (Pubitemid 27366829)
49. Anderlová K., Křemen J., Doležalová R., Housová J J., Haluzíková D., Kunešová M., Haluzík M., The influence of very-low-calorie diet on serum leptin, soluble leptin receptor, adiponectin and resistin levels in obese women. Physiological Research 2006 55 3 277 283 2-s2.0-33745197792
50. Mazzali G., Di Francesco V., Zoico E., Fantin F., Zamboni G., Benati C., Bambara V., Negri M., Bosello O., Zamboni M., Interrelations between fat distribution, muscle lipid content, adipocytokines, and insulin resistance: Effect of moderate weight loss in older women. The American Journal of Clinical Nutrition 2006 84 5 1193 1199 2-s2.0-33750912416 (Pubitemid 44730392)
51. Klimcakova E., Kovacikova M., Stich V., Langin D., Adipokines and dietary interventions in human obesity. Obesity Reviews 2010 11 6 446 456 2-s2.0-77952747823 10.1111/j.1467-789X.2009.00704.x
52. Klempel M. C., Varady K. A., Reliability of leptin, but not adiponectin, as a biomarker for diet-induced weight loss in humans. Nutrition Reviews 2011 69 3 145 154 2-s2.0-79951933015 10.1111/j.1753-4887.2011.00373.x
53. Berrington de Gonzalez A., Hartge P., Cerhan J. R., Body-mass index and mortality among 1. 46 million white adults. The New England Journal of Medicine 2010 363 2211 2219 10.1056/NEJMoa1000367
54. Flegal K. M., Kit B. K., Orpana H., Graubard B. I., Association of all-cause mortality with overweight and obesity using standard body mass index categories: a systematic review and meta-analysis. Journal of the American Medical Association 2013 309 1 71 82 10.1001/jama.2012.113905
55. Folsom A. R., Qamhieh H. T., Wing R. R., Jeffery R. W., Stinson V. L., Kuller L. H., Wu K. K., Impact of weight loss on plasminogen activator inhibitor (PAI-1), factor VII, and other hemostatic factors in moderately overweight adults. Arteriosclerosis and Thrombosis 1993 13 2 162 169 2-s2.0-0027530758 (Pubitemid 23056789)
56. Mertens I., Van Gaal L. F., Obesity, haemostasis and the fibrinolytic system. Obesity Reviews 2002 3 2 85 101 2-s2.0-0036322988 10.1046/j.1467-789X. 2002.00056.x (Pubitemid 34827150)
57. Carpenter G., Cohen S., Epidermal growth factor. The Journal of Biological Chemistry 1990 265 14 7709 7712 2-s2.0-0025321157 (Pubitemid 20158927)
58. Grau M., Rodríguez C., Soley M., Ramírez I., Relationship between epidermal growth factor in mouse submandibular glands, plasma, and bile: effects of catecholamines and fasting. Endocrinology 1994 135 5 1854 1862 2-s2.0-0027967961 10.1210/en.135.5.1854 (Pubitemid 24363876)
59. Gogg S., Smith U., Epidermal growth factor and transforming growth factor mimic the effects of insulin in human fat cells and augment downstream signaling in insulin resistance. Journal of Biological Chemistry 2002 277 39 36045 36051 2-s2.0-0037183974 10.1074/jbc.M200575200
60. Schlessinger J., Ullrich A., Growth factor signaling by receptor tyrosine kinases. Neuron 1992 9 3 383 391 2-s2.0-0026793456 10.1016/0896-6273(92)90177-F
61. Kasayama S., Ohba Y., Oka T., Epidermal growth factor deficiency associated with diabetes mellitus. Proceedings of the National Academy of Sciences of the United States of America 1989 86 19 7644 7648 2-s2.0-3242871566 (Pubitemid 19254511)
62. Strissel K. J., Stancheva Z., Miyoshi H., Perfield J. W. II, DeFuria J., Jick Z., Greenberg A. S., Obin M. S., Adipocyte death, adipose tissue remodeling, and obesity complications. Diabetes 2007 56 12 2910 2918 2-s2.0-36849012057 10.2337/db07-0767 (Pubitemid 350223625)
63. Skurk T., Alberti-Huber C., Herder C., Hauner H., Relationship between adipocyte size and adipokine expression and secretion. Journal of Clinical Endocrinology and Metabolism 2007 92 3 1023 1033 2-s2.0-33947502786 10.1210/jc.2006-1055 (Pubitemid 46465679)
64. Lelliott C., Vidal-Puig A. J., Lipotoxicity, an imbalance between lipogenesis de novo and fatty acid oxidation. International Journal of Obesity 2004 28 4 S22 S28 2-s2.0-12444334643 10.1038/sj.ijo.0802854 (Pubitemid 40143845)